Your browser doesn't support javascript.
loading
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapy.
Du, L; Yau, C; Brown-Swigart, L; Gould, R; Krings, G; Hirst, G L; Bedrosian, I; Layman, R M; Carter, J M; Klein, M; Venters, S; Shad, S; van der Noordaa, M; Chien, A J; Haddad, T; Isaacs, C; Pusztai, L; Albain, K; Nanda, R; Tripathy, D; Liu, M C; Boughey, J; Schwab, R; Hylton, N; DeMichele, A; Perlmutter, J; Yee, D; Berry, D; Van't Veer, L; Valero, V; Esserman, L J; Symmans, W F.
Afiliação
  • Du L; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Yau C; Department of Surgery, University of California, San Francisco, USA.
  • Brown-Swigart L; Department of Pathology, University of California, San Francisco, USA.
  • Gould R; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Krings G; Department of Pathology, University of California, San Francisco, USA.
  • Hirst GL; Department of Surgery, University of California, San Francisco, USA.
  • Bedrosian I; Department of Breast Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Layman RM; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Carter JM; Department of Pathology, Mayo Clinic, Rochester, USA.
  • Klein M; Department of Pathology, University of Minnesota, Minneapolis, USA.
  • Venters S; Department of Surgery, University of California, San Francisco, USA.
  • Shad S; Department of Surgery, University of California, San Francisco, USA.
  • van der Noordaa M; Department of Surgery, University of California, San Francisco, USA.
  • Chien AJ; Department of Medicine, University of California, San Francisco, USA.
  • Haddad T; Department of Medicine, Mayo Clinic, Rochester, USA.
  • Isaacs C; Department of Medicine, Georgetown University, Washington, USA.
  • Pusztai L; Department of Medicine, Yale University School of Medicine, New Haven, USA.
  • Albain K; Department of Medicine, Loyola University, Chicago, USA.
  • Nanda R; Department of Medicine, University of Chicago, Chicago, USA.
  • Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Liu MC; Department of Medicine, Mayo Clinic, Rochester, USA.
  • Boughey J; Department of Surgery, Mayo Clinic, Rochester, USA.
  • Schwab R; Department of Medicine, University of California, San Diego, USA.
  • Hylton N; Department of Radiology, University of California, San Francisco, USA.
  • DeMichele A; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, San Philadelphia, USA.
  • Perlmutter J; Gemini Group, Ann Arbor, USA.
  • Yee D; Department of Medicine, University of Minnesota, Minneapolis, USA.
  • Berry D; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Van't Veer L; Department of Pathology, University of California, San Francisco, USA.
  • Valero V; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Esserman LJ; Department of Surgery, University of California, San Francisco, USA.
  • Symmans WF; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Pathology, The University of Texas MD Anderson Cancer Center, San Francisco, USA. Electronic address: fsymmans@mdanderson.org.
Ann Oncol ; 32(5): 642-651, 2021 05.
Article em En | MEDLINE | ID: mdl-33617937
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2021 Tipo de documento: Article